No leg leans either way.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Oct 4, 2023 | Sakiris Spiro Kevin | Chief Financial Officer | Buy (P) | 113K | — |
| Oct 4, 2023 | Towers Christopher | Director | Buy (P) | 9K | — |
| Sep 1, 2023 | Simeonidis Harry | CEO | Buy (P) | 50 | $93 |
| Aug 31, 2023 | Simeonidis Harry | CEO | Buy (P) | 100 | $192 |
| Jun 22, 2022 | Sakiris Spiro Kevin | Chief Financial Officer | Buy (P) | 5K | $3K |
| Jun 17, 2022 | Sakiris Spiro Kevin | ChiefFinancial Officer | Buy (P) | 16K | $10K |
| Feb 17, 2022 | Life Science Biosensor Diagnostics Pty Ltd | Insider | Sell (S) | 576K | $294K |
| Feb 16, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell (S) | 100K | $63K |
| Feb 15, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell (S) | 100K | $68K |
| Feb 14, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell (S) | 100K | $70K |
| Feb 11, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell (S) | 100K | $75K |
| Feb 10, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell (S) | 100K | $84K |
No institutional, insider, or congressional activity for GBS in the last 180 days.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 0 | 0 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for GBS
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/GBS/capital-change-brief"
Use Arkolith's capital_change_brief for GBS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for GBS. Filings are public domain, sourced to SEC EDGAR.